Literature DB >> 29403334

Surgical approach to limiting skin contracture following protractor myectomy for essential blepharospasm.

Jeremy Clark1, John Randolph1, Jason A Sokol2, Nicholas A Moore3, Hui Bae H Lee3, William R Nunery1,3.   

Abstract

PURPOSE: To report our experience with protractor myectomy in patients with benign essential blepharospasm who did not respond to serial botulinum toxin injection, and to describe intra- and postoperative techniques that limited skin contracture while also providing excellent functional and cosmetic results.
METHODS: The medical records of patients with isolated, benign, essential blepharospasm who underwent protractor myectomy from 2005 to 2008 by a single surgeon were reviewed retrospectively. The technique entailed operating on a single eyelid during each procedure, using a complete en bloc resection of all orbicularis tissue, leaving all eyelid skin intact at the time of surgery, and placing the lid under stretch with Frost suture and applying a pressure dressing for 5-7 days.
RESULTS: Data from 28 eyelids in 7 patients were included. Average follow-up was 21.5 months (range, 4-76 months). Of the 28 eyelids, 20 (71.4%) showed postoperative resolution of spasm, with no further need for botulinum toxin injections. In the 8 eyelids requiring further injections, the average time to injection after surgery was 194 days (range, 78-323 days), and the average number of injections was 12 (range, 2-23 injections). All but one eyelid had excellent cosmetic results, without signs of contracture; one eyelid developed postoperative skin contracture following premature removal of the Frost suture and pressure dressing because of concerns over increased intraocular pressure.
CONCLUSIONS: In our patient cohort, this modified technique resulted in excellent cosmetic and functional results and limited postoperative skin contracture.

Entities:  

Mesh:

Year:  2017        PMID: 29403334      PMCID: PMC5791625          DOI: 10.5693/djo.01.2016.11.001

Source DB:  PubMed          Journal:  Digit J Ophthalmol        ISSN: 1542-8958


  28 in total

Review 1.  Botulinum toxin management of upper facial rhytidosis and blepharospasm.

Authors:  Stuart R Seiff; Orin M Zwick
Journal:  Otolaryngol Clin North Am       Date:  2005-10       Impact factor: 3.346

Review 2.  Surgical management of essential blepharospasm.

Authors:  Bhupendra C K Patel
Journal:  Otolaryngol Clin North Am       Date:  2005-10       Impact factor: 3.346

3.  Botulinum toxin a in the treatment of blepharospasm: a 10-year experience.

Authors:  Laura Silveira-Moriyama; Lilian R Gonçalves; Hsin Fen Chien; Egberto R Barbosa
Journal:  Arq Neuropsiquiatr       Date:  2005-06       Impact factor: 1.420

4.  Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial.

Authors:  Daniel Truong; Cynthia Comella; Hubert H Fernandez; William G Ondo
Journal:  Parkinsonism Relat Disord       Date:  2008-03-05       Impact factor: 4.891

Review 5.  Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.

Authors:  R Bhidayasiri; F Cardoso; D D Truong
Journal:  Eur J Neurol       Date:  2006-02       Impact factor: 6.089

6.  Effects of eyelid protractor excision for the treatment of benign essential blepharospasm.

Authors:  B R Frueh; D C Musch; T A Bersani
Journal:  Am J Ophthalmol       Date:  1992-06-15       Impact factor: 5.258

7.  Follow-up of patients with essential blepharospasm who underwent eyelid protractor myectomy at the Mayo Clinic from 1980 through 1995.

Authors:  K L Chapman; G B Bartley; R R Waller; D O Hodge
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1999-03       Impact factor: 1.746

8.  Frontalis suspension combined with blepharoplasty as an effective treatment for blepharospasm associated with apraxia of eyelid opening.

Authors:  V De Groot; F De Wilde; L Smet; M J Tassignon
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2000-01       Impact factor: 1.746

Review 9.  Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.

Authors:  C Kenney; J Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2007-06-11       Impact factor: 3.575

10.  Blepharospasm: a review of 264 patients.

Authors:  F Grandas; J Elston; N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.